(S,R,S)-AHPC is a highly selective E3 ligase ligand designed for use in PROTAC (Proteolysis Targeting Chimera) technology. As a derivative of von Hippel-Lindau (VHL) ligand, (S,R,S)-AHPC facilitates the recruitment of VHL E3 ubiquitin ligase, enabling targeted protein ubiquitination and subsequent proteasomal degradation. Belonging to the category of E3 Ligase Ligands, (S,R,S)-AHPC is an essential chemical tool for researchers working on PROTAC drug development and targeted protein degradation platforms. Typical applications include conjugation to various target-binding moieties to develop VHL-based PROTAC molecules for studying, regulating, or degrading disease-associated proteins. This compound accelerates the discovery of next-generation therapeutics across oncology, neuroscience, and other disease areas where precise protein knockdown is paramount.
Structure of 1448297-52-6
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $293 | In stock | |
| 1 g | $999 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC is a highly specialized ligand designed for recruiting the von Hippel-Lindau (VHL) E3 ubiquitin ligase, a central component in the ubiquitin-proteasome system (UPS). VHL ligands like (S,R,S)-AHPC are widely utilized in the construction of PROTACs (Proteolysis Targeting Chimeras), enabling selective protein degradation via VHL-mediated ubiquitination pathways. The (S,R,S) stereochemistry of AHPC ensures optimal binding affinity and specificity for the VHL protein, making it a cornerstone moiety for advanced targeted protein degradation strategies.
Mechanism
(S,R,S)-AHPC functions by specifically binding to the VHL E3 ligase, facilitating its recruitment within bifunctional molecules such as PROTACs. Upon conjugation to a ligand that binds a protein of interest, the PROTAC molecule brings the target protein in proximity to the VHL E3 ligase complex. This interaction triggers polyubiquitination of the target protein, marking it for recognition and degradation by the cell's 26S proteasome. The (S,R,S)-stereochemistry is critical for maximizing potency and maintaining selectivity toward the VHL binding pocket, improving the efficacy of the resultant degraders.
Applications
(S,R,S)-AHPC is a core building block for the synthesis of VHL-based PROTACs and targeted protein degradation tools. Its robust chemical properties and well-characterized binding capacity make it an ideal choice for researchers aiming to develop next-generation degraders for basic research or therapeutic applications. Main uses include:
• Construction of VHL-recruiting PROTACs for preclinical and clinical research
What is the activity of (S,R,S)-AHPC?
(S,R,S)-AHPC is a VHL ligand that can be used to synthesize PROTAC molecules as part of the recruitment of Von Hippel-Lindau (VHL) proteins.
28/6/2022
PROTAC synthesis
I used (S,R,S)-AHPC as a starting material to synthesize GMB-475 and tested the level of degradation of BCR-ABL1 induced by GMB-475. The experiment is going well!
28/8/2022
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.